PVCT = 0.13 US dollar
+0.011 USD (+8.36%)
iyipada owo ayipada niwon ọjọ
Iyipada ni idiyele ọja ti Provectus Biopharmaceuticals, Inc. ni US dollar waye lẹẹkan ni ọjọ kan. Fihan idiyele ọja ikẹhin ti Provectus Biopharmaceuticals, Inc. ni US dollar. Ọja iṣura lati Provectus Biopharmaceuticals, Inc. in US dollar lati awọn apoti isura data igbẹkẹle. Iṣura 1 ti Provectus Biopharmaceuticals, Inc. ni bayi 0.13 iṣura ti US dollar. Iṣura 1 ti Provectus Biopharmaceuticals, Inc. pọ nipasẹ 0.011 US dollar. Provectus Biopharmaceuticals, Inc. dide ibatan ninu US dollar niwon lana.
|
Provectus Biopharmaceuticals, Inc. ile-iṣẹ ti ipin ni US dollar
Ni ọsẹ kan sẹyin, Provectus Biopharmaceuticals, Inc. le ṣee ra fun 0.13 US dollar. Ni oṣu kan sẹhin, Provectus Biopharmaceuticals, Inc. ni a le paarọ fun 0 US dollar. Oṣu mẹfa sẹyin, a le paarọ Provectus Biopharmaceuticals, Inc. fun 0 US dollar. Provectus Biopharmaceuticals, Inc. idiyele ọja ni US dollar jẹ rọrun lati wo lori aworan apẹrẹ. 0.86% ni ọsẹ kan - iyipada ninu idiyele ọja ti Provectus Biopharmaceuticals, Inc.. Ni oṣu, Provectus Biopharmaceuticals, Inc. ni US dollar owo iṣura ti yipada nipasẹ 0%.
|
Awọn abajade iṣura Provectus Biopharmaceuticals, Inc. US dollar
PVCT To US dollar (USD)
|
1 PVCT |
0.13 US dollar |
5 PVCT |
0.67 US dollar |
10 PVCT |
1.35 US dollar |
25 PVCT |
3.37 US dollar |
50 PVCT |
6.74 US dollar |
100 PVCT |
13.49 US dollar |
250 PVCT |
33.71 US dollar |
500 PVCT |
67.43 US dollar |
Loni, 10 iṣura ti Provectus Biopharmaceuticals, Inc. le ṣe paarọ fun 1.35 US dollar. Ti o ba ni 25 iṣura ti Provectus Biopharmaceuticals, Inc., lẹhinna wọle awọn British Virgin Islands o le ra 3.37 US dollar. O le ṣe paṣipaarọ 6.74 US dollar fun iṣura 50 iṣura ti Provectus Biopharmaceuticals, Inc.. Loni, a le ra 100 iṣura ti Provectus Biopharmaceuticals, Inc. le ṣee ra fun 13.49 US dollar. Loni, a le ra 33.71 US dollar le ṣee ra fun 250 iṣura ti Provectus Biopharmaceuticals, Inc.. Ti o ba ni 67.43 US dollar, lẹhinna wọle awọn British Virgin Islands a le ta wọn fun 500 iṣura ti Provectus Biopharmaceuticals, Inc..
|